Joint Formulary & PAD

Procyclidine hydrochloride - Dystonic reactions

You are here : Home > Formulary Search > Procyclidine hydrochloride - Dystonic reactions

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Injection
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Procyclidine hydrochloride
Indication :
Dystonic reactions
Group Name :
Keywords :
acute dystonia, drug induced extrapyramidal symptoms
Brand Names Include :
Important Information :

Procyclidine injection has been discontinued. There may be supplies available until mid-February 2026.
See link for details: https://www.sps.nhs.uk/shortages/discontinuation-of-procyclidine-10mg-2ml-solution-for-injection-ampoules/
Updated advice is expected from the NPIS by the end of 2025. Benztropine (unlicensed in the UK) may be considered as an alternative. A formulary entry for benztropine will be created once agreed for use by Surrey Heartands Acute Trusts.

https://www.toxbase.org/

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (1)

05 Feb 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

Other Indications

Below are listed other indications that Procyclidine hydrochloride is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Dystonic reactions.

  • No records returned.